- Home
- MRNA vs WYNN Comparison
MRNA vs WYNN Comparison
Compare MRNA & WYNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | WYNN |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 13.5B |
| IPO Year | 2018 | 2002 |
Fundamental Metrics
Financial Performance| Metric | MRNA | WYNN |
|---|---|---|
| Price | $27.57 | $125.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 13 |
| Target Price | $33.91 | ★ $139.31 |
| AVG Volume (30 Days) | ★ 9.9M | 1.7M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.59 |
| Revenue | $2,232,000,000.00 | ★ $7,110,738,000.00 |
| Revenue This Year | N/A | $1.96 |
| Revenue Next Year | $0.77 | $3.59 |
| P/E Ratio | ★ N/A | $27.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.28 | $65.25 |
| 52 Week High | $48.92 | $134.72 |
Technical Indicators
Market Signals| Indicator | MRNA | WYNN |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 50.63 |
| Support Level | $23.92 | $123.34 |
| Resistance Level | $26.00 | $133.98 |
| Average True Range (ATR) | 1.29 | 4.26 |
| MACD | 0.32 | 0.37 |
| Stochastic Oscillator | 99.82 | 53.49 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About WYNN Wynn Resorts Limited Common stock
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform, in a few states. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.